Urinary 8-hydroxy-2'-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer's disease. (Q53323969)

13 May 2018

title

Urinary 8-hydroxy-2'-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer's disease. (English)

1 reference

13 May 2018

author name string

Oğuzhan Zengi

1

1 reference

13 May 2018

Alpaslan Karakas

2

1 reference

13 May 2018

Ufuk Ergun

3

1 reference

13 May 2018

Mehmet Senes

4

1 reference

13 May 2018

Levent Inan

5

1 reference

13 May 2018

Dogan Yucel

6

1 reference

13 May 2018

publication date

18 November 2011

1 reference

13 May 2018

Clinical Chemistry and Laboratory Medicine

published in

1 reference

13 May 2018

volume

50

1 reference

13 May 2018

page(s)

529-534

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

Circulating cancer cells and their clinical applications.

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Leptin: the missing link in Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Age, Alzheimer disease, and brain structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Risk factors for Alzheimer disease: aging beyond age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Induction of oxidative stress and DNA damage in rat brain by a folate/methyl-deficient diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

A clinical registry of dementia based on the principle of epidemiological surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

High total cholesterol levels in late life associated with a reduced risk of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Method for the analysis of 8-hydroxy-2'-deoxyguanosine in urine by gas chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Biomarkers in Alzheimer's disease: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.792

21 January 2018

Identifiers

DOI

10.1515/CCLM.2011.792

1 reference

13 May 2018

PubMed ID

22098435

1 reference

13 May 2018